Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sets New 52-Week Low – Here’s Why

Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) hit a new 52-week low during trading on Wednesday . The company traded as low as $6.76 and last traded at $6.81, with a volume of 1225637 shares traded. The stock had previously closed at $6.95.

Analysts Set New Price Targets

Separately, Bank of America upgraded Bayer Aktiengesellschaft from an “underperform” rating to a “neutral” rating in a research report on Friday, September 6th. One analyst has rated the stock with a sell rating and eight have assigned a hold rating to the company. According to data from MarketBeat.com, Bayer Aktiengesellschaft currently has a consensus rating of “Hold”.

Bayer Aktiengesellschaft Trading Up 0.4 %

The company has a current ratio of 1.27, a quick ratio of 0.86 and a debt-to-equity ratio of 1.04. The business has a 50 day moving average of $7.64 and a two-hundred day moving average of $7.47. The firm has a market cap of $26.72 billion, a P/E ratio of -18.81 and a beta of 1.08.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.25 EPS for the quarter, hitting analysts’ consensus estimates of $0.25. Bayer Aktiengesellschaft had a positive return on equity of 16.96% and a negative net margin of 2.74%. The firm had revenue of $12 billion for the quarter. Analysts predict that Bayer Aktiengesellschaft will post 1.38 earnings per share for the current year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.